Flibanserin for Hypoactive Sexual Desire Disorder: An Open-Label Safety Study.
Simon JA, Derogatis L, Portman D, Brown L, Yuan J, Kissling R.
Simon JA, et al. Among authors: portman d.
J Sex Med. 2018 Mar;15(3):387-395. doi: 10.1016/j.jsxm.2017.12.016.
J Sex Med. 2018.
PMID: 29502984
CONCLUSION: In this open-label study, flibanserin 100 mg once daily at bedtime was generally safe and well tolerated by premenopausal and naturally postmenopausal women with HSDD. Simon JA, Derogatis L, Portman D, et al. Flibanserin for Hypoactive Sexual Desire Diso …
CONCLUSION: In this open-label study, flibanserin 100 mg once daily at bedtime was generally safe and well tolerated by premenopausal and na …